Injewelme Raises $1.2M in Funding Round Led by Temasek Trust's Catalytic Capital for Climate and Health

Why It Matters

The funding accelerates deployment of scalable, non‑invasive monitoring that can improve preventive care, eldercare and climate‑related health risk management across the rapidly expanding APAC health‑tech sector.

Key Takeaways

• injewelme raised $1.2M led by Temasek's Catalytic Capital.
• DeepHealthVision measures 20+ vitals in 30 seconds via camera.
• Pilot tests showed 95% accuracy across Singapore clinics.
• Funds will target glucose, stress, fatigue monitoring and SE Asia expansion.
• Contactless health tech supports climate‑related stress monitoring and eldercare.

Pulse Analysis

Contactless health monitoring is emerging as a cornerstone of next‑generation preventive care, leveraging AI and remote photoplethysmography to capture physiological data without physical contact. By converting subtle color changes in a video feed into reliable metrics such as blood pressure and oxygen saturation, platforms like injewelme’s DeepHealthVision can deliver rapid, clinician‑grade insights in under a minute. This capability not only reduces infection risk and streamlines workflow but also opens new data streams for population‑level health analytics, a critical advantage as healthcare systems grapple with aging demographics and rising chronic disease burdens.

Injewelme’s recent $1.2 million infusion, anchored by Temasek’s Catalytic Capital for Climate and Health, underscores investor confidence in the commercial viability of such technology. The startup’s pilots with Singapore’s SingHealth Polyclinics demonstrated 95% detection accuracy, a benchmark that validates its AI‑driven algorithms and positions the firm for broader adoption. The capital will be allocated to expand the sensor suite—adding blood‑glucose, stress index, fatigue and hydration monitoring—while accelerating market entry across Southeast Asia. These enhancements aim to diversify use cases, from eldercare facilities to corporate wellness programs, and to meet the growing demand for remote health solutions in regions with limited clinical infrastructure.

The raise also reflects a larger funding wave for APAC health‑tech innovators, exemplified by Temasek‑backed Dozee and South Korea’s Sky Labs, indicating a strategic focus on technologies that can address climate‑induced health stresses. As heatwaves intensify, the ability to monitor physiological stress non‑invasively becomes a public‑health imperative, creating synergies between health monitoring and climate resilience. Consequently, injewelme is well‑positioned to capture market share, attract additional strategic partners, and contribute to a more data‑rich, proactive healthcare ecosystem.

Deal Summary

Singapore-based health‑tech startup injewelme announced it has closed a $1.2 million funding round, led by Temasek Trust’s Catalytic Capital for Climate and Health with participation from the Richardson Family. The capital will be used to advance its contactless health monitoring technology and expand across Southeast Asia.